DISSOLUTION PROFILE STUDY FOR EXTENDED RELEASE VALPROIC ACID DOSAGE FORM (DEPAKINE® CHRONO)

Dissolution profile study for extended-release valproic acid preparations was performed in three dissolution media: 0.1 M hydrochloric acid, acetate buffer pH 4.5, citrate-phosphate buffer pH 6.8 using Apparatus 1 at 75 rpm. Time points were 1, 2, 3, 4, and 6 hours. Assay of released API was perform...

Full description

Bibliographic Details
Main Authors:	A. A. Lvova, Yu. E. Boldina, I. E. Shohin, T. N. Komarov, L. A. Menshikova, Yu. V. Medvedev
Format:	Article
Language:	Russian
Published:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2019-01-01
Series:	Разработка и регистрация лекарственных средств
Subjects:	вальпроевая кислота растворение вэжх
Online Access:	https://www.pharmjournal.ru/jour/article/view/303

Similar Items

DISSOLUTION PROFILE STUDY OF EXTENDED RELEASE VALPROIC ACID DRUG PRODUCTS FROM DIFFERENT MANUFACTURERS
by: D. Yu. Grebenkin, et al.
Published: (2019-01-01)

Особенности фармакокинетики пролонгированных лекарственных форм вальпроевой кислоты, имеющихся в России
Published: (2018-06-01)

Study of the anti-inflammatory and immunotropic activity of the secretome from multipotent mesenchymal stromal cells induced by erythropoietin, valproic acid or dexamethasone <i>in vitro</i>
by: P. A. Golubinskaya, et al.
Published: (2022-04-01)

Clinical-economic analysis of valproate microsphere form in focal epilepsy in adults (real world evidences)
by: D. Yu. Belousov, et al.
Published: (2018-05-01)

Shall we treat patients with benign epileptiform discharges of childhood without epileptic seizures?
by: N. A. Ermolenko, et al.
Published: (2019-05-01)

EVALUATION OF THE AUTOMATION INFLUENCE ON THE DISSOLUTION VARIABILITY RESULTS FOR BETASERC TABLETS
by: N. S. Dubovik, et al.
Published: (2019-01-01)

Development and Validation of Tranexamic Acid Determination in Human Plasma by HPLC-MS/MS method
by: A. V. Aleshina, et al.
Published: (2021-05-01)

DEVELOPMENT AND VALIDATION OF MOXIFLOXACIN DETERMINATION IN HUMAN PLASMA BY HPLC-UV METHOD
by: T. N. Komarov, et al.
Published: (2019-01-01)

Вальпроевая кислота: клинико-экономический анализ реальной практики лечения эпилепсии подростков
Published: (2018-06-01)

DISSOLUTION PROFILE STUDY FOR INNOVATION ANTI-RETROVIRAL DRUG PRODUCT NIKAVIR® AND ITS FIXED COMBINATION WITH LAMIVUDINE (PHOSPHALADINE®)
by: I. E. Shohin, et al.
Published: (2019-01-01)

Therapy of neonatal seizures: a two-year retrospective study at Almazov National Medical Research Centre
by: D. V. Novoseltsev, et al.
Published: (2020-05-01)

Development and Validation of Tadalafil Determination in Human Plasma by HPLC-MS Method
by: D. S. Bogdanova, et al.
Published: (2019-05-01)

Development and Validation of Atazanavir and Ritonavir Determination in Human Plasma by HPLC-MS Method
by: T. N. Komarov, et al.
Published: (2020-02-01)

Study of the Pharmaceutical Grade Polymers effect on the Dissolution of Practically Insoluble Antiretroviral Substances
by: S. A. Zolotov, et al.
Published: (2022-05-01)

DISINTEGRANTS AND THEIR INFLUENCE ON THE DISSOLUTION OF SUBSTANCES OF BIOPHARMACEUTICAL CLASSIFICATION SYSTEM CLASSES
by: I. E. Smekhova, et al.
Published: (2019-01-01)

DISSOLUTION MEDIA USED IN DEVELOPMENT AND QUALITY CONTROL OF DRUGS
by: O. V. Druzhininskaya, et al.
Published: (2019-01-01)

VALIDATION OF UV-SPECTROMETRY ASSAY METHOD FOR DISSOLUTION PROFILE TEST FOR LEVOFLOXACINE TABLETS
by: A. A. Lvova, et al.
Published: (2019-01-01)

VALIDATION OF UV-SPECTROMETRY ASSAY METHOD FOR DISSOLUTION PROFILE TEST FOR MOXIFLOXACINE TABLETS
by: L. A. Menshikova, et al.
Published: (2019-01-01)

DETERMINATION OF CAPECITABINE AND ITS ACTIVE METABOLITE 5-FLUOROURACIL IN BLOOD PLASMA BY HPLC-MS/MS
by: E. S. Melnikov, et al.
Published: (2019-01-01)

Development and Validation of Valganciclovir and its Active Metabolite Ganciclovir Determination in Human Plasma by HPLC-UV Method
by: T. N. Komarov, et al.
Published: (2020-05-01)

Physical and Chemical Properties and Quality Control Methods of Hyaluronic Acid (Review)
by: A. Kh. Amandusova, et al.
Published: (2020-11-01)

USE OF DISSOLUTION TEST FOR EVALUATION OF PHARMACEUTICAL EQUIVALENCE OF ATORVASTATIN GENERICS
by: O. V. Druzhininskaya, et al.
Published: (2019-01-01)

Therapeutic and biopharmaceutical assessment of indapamide medications
by: G. V. Ramenskaya, et al.
Published: (1970-01-01)

PHLEBOPROTECTORS BASED ON FLAVONOIDS: DOSAGE FORMS, BIOPHARMACEUTICAL CHARACTERISTICS, TECHNOLOGICAL FEATURES
by: E. F. Stepanova, et al.
Published: (2021-05-01)

Development and Validation of Salbutamol, Bromhexine, Ambroxol and Guauaifenesin Determination in Human Plasma by HPLC-MS/MS Method
by: T. N. Komarov, et al.
Published: (2019-11-01)

Development and Validation of Pomalidomide Determination in Human Plasma by HPLC-MS/MS Method
by: T. N. Komarov, et al.
Published: (2020-11-01)

Study of the Technological Methods Effect on Dissolution of the X-ray Amorphous Efavirenz-mesoporous Carrier System
by: S. A. Zolotov, et al.
Published: (2022-09-01)

THE FEATURES OF THE PREDICTIVE DISSOLUTION TESTING (REVIEW)
by: R. I. Moustafine, et al.
Published: (2019-01-01)

Development of the "Dissolution" Test Method for Tablets of Sodium 4,4'-(propanediamido)dibenzoate with Sustained Release
by: E. V. Flisyuk, et al.
Published: (2021-12-01)

DEVICE FOR CAUTERY OF BLEEDING USING A SALT WITH LOW CRYOHYDRATE DISSOLUTION TEMPERATURE
by: K. S. Gulmagomedov, et al.
Published: (2018-12-01)

Development and Validation of Valganciclovir and its Active Metabolite Ganciclovir Determination in Human Plasma by HPLC-MS/MS Method
by: T. N. Komarov, et al.
Published: (2021-02-01)

Russian observational study of the efficacy and tolerability of depakine chrono as first-line monotherapy for focal epilepsy
by: E. D. Belousova
Published: (2010-09-01)

The routine practice of therapeutic drug monitoring - some of the results of work in the system of CHI
by: V. A. Baturin, et al.
Published: (2018-05-01)

The validation of method HPLC-determination of zolpidem in biological liquids
by: Y A Khomov, et al.
Published: (2010-09-01)

Development and Validation of HPLC-UV Method for the Determination of Favipiravir in Human Plasma
by: T. N. Komarov, et al.
Published: (2022-09-01)

HPLC-UV Method Development and Validation for Vitamin D<sub>3</sub> (Cholecalciferol) Quantitation in Drugs and Dietary Supplements
by: I. E. Shohin, et al.
Published: (2021-05-01)

Assessing the impact of the automation on the variability of the «Dissolution» test results as exemplified by «Betahistine hydrochloride tablets 16 mg»
by: G. F. Vasilenko, et al.
Published: (2018-02-01)

EFFECT OF HYDROXYETHYLCELLULOSE ON THE RELEASE OF GLIBENCLAMIDE FROM SUSTAINED RELEASE TABLETS
by: S. V. Trofimov
Published: (2019-01-01)

Development and Validation of a Method for Determining Deferasirox in Human Blood Plasma by HPLC-UV
by: P. A. Karpova, et al.
Published: (2022-05-01)

Determination of Lappaconitin, Diterpene Alkaloide Obtained from Plants <i>Aconitum leucostomum</i>, and its Active Metabolite N-desacetyllappaconitin in Human Plasma and Blood
by: O. A. Archakova, et al.
Published: (2021-08-01)